Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673870 | SCV000799122 | likely pathogenic | Holocarboxylase synthetase deficiency | 2018-04-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000673870 | SCV001416485 | pathogenic | Holocarboxylase synthetase deficiency | 2020-09-17 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu420*) in the HLCS gene. It is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with HLCS-related conditions. ClinVar contains an entry for this variant (Variation ID: 557697). Loss-of-function variants in HLCS are known to be pathogenic (PMID: 16134170). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000673870 | SCV004199834 | likely pathogenic | Holocarboxylase synthetase deficiency | 2023-08-10 | criteria provided, single submitter | clinical testing |